<DOC>
	<DOCNO>NCT01755429</DOCNO>
	<brief_summary>This protocol intend formally collect data treatment aHUS eculizumab Japanese patient .</brief_summary>
	<brief_title>To Characterize Safety Tolerability Eculizumab Two Japanese aHUS Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Azotemia</mesh_term>
	<mesh_term>Hemolytic-Uremic Syndrome</mesh_term>
	<mesh_term>Atypical Hemolytic Uremic Syndrome</mesh_term>
	<criteria>1 . Patient and/or legal guardian must willing able give write informed consent id patient adult able read write , patient willing give write informed assent 2 . Eculizumab treatment initiate personal importation aHUS 201</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>